Xebio Holdings Co., Ltd. announced consolidated earnings results for the fourth quarter and year ended March 31, 2017. For the year, on consolidated basis, the company's net sales were JPY 223,353 million compared to JPY 221,391 million a quarter ago. Operating profit was JPY 7,428 million compared to JPY 6,169 million a quarter ago. Ordinary profit was JPY 7,499 million compared to JPY 6,396 million a quarter ago. Net profit was JPY 2,991 million compared to JPY 2,120 million a year ago. Net cash provided by operating activities was JPY 10,444 million compared to JPY 5,138 million a year ago. Capital expenditure was JPY 5,127 million compared to JPY 7,073 million a year ago.

For the quarter, on consolidated basis, the company reported net sales of JPY 54,896 million, operating profit of JPY 473 million, ordinary profit of JPY 839 million and net profit of JPY 300 million.

For the fiscal year 2018, the company expects net sales of JPY 240,420 million, operating profit of JPY 8,928 million, ordinary profit of JPY 9,500 million and net profit of JPY 4,124 million.